Cision PR Newswire

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data...

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

ITASCA, Ill., Feb. 15, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a...

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

SHENZHEN, China, Feb. 15, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services...